Last reviewed · How we verify

NCT05516394: PL-MILS

National Polish Registry of Minimally Invasive Liver Surgery

Status unknown Last updated 25 August 2022
What this trial tests

trial testing Laparoscopic liver resection in Liver Tumor in 1,000 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
31 December 2022
31 December 2025

Quick facts

Lead sponsorMedical University of Warsaw
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 July 2020
Primary completion31 December 2022
Estimated completion31 December 2025
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Warsaw

Who can join

18 and older, any sex, with Liver Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After the two consensus meetings on laparoscopic liver resection in Louisville (2008) and in Morioka (2014) minimally invasive approach for liver resection was finally widely established in liver surgery practice. Successively more countries follow laparoscopic liver pioneers and apply laparoscopic liver surgery for everyday practice. Primary aim of the study is to assess the evolution and diffusion of minimally invasive liver surgery in Poland. Secondly, it will allow to assess the actual short- and long-term results of laparoscopic liver resections and compare it to the international benchmark values. The National Polish Registry of Minimally Invasive Liver Surgery will include data about all cases of laparoscopic liver resections performed in Poland since the first case in 2010. All surgical departments, where laparoscopic liverresection is regularly performed, will be invited. Data of demography, previous medical history, preoperative assessment, intraoperative and postoperative period, histopathological findings and long-term follow-up will be included in the registry. This study will be the first national report about diffusion of minimally invasive surgery in Poland.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Early adoption of laparoscopic liver surgery in Poland: a national retrospective cohort study.
    Hołówko W, Serednicki W, Bartkowiak M, Wysocki M, et al · · 2024 · cited 10× · PMID 37816169 · DOI 10.1097/js9.0000000000000840
  2. Is operation time over the benchmark value a risk factor for worse short-term outcomes after laparoscopic liver resection?
    Hołówko W, Rykowski P, Wyporski A, Serednicki W, et al · · 2024 · cited 1× · PMID 38974769 · DOI 10.5114/wiitm.2024.135446

Verify or expand the search:

Other trials of Laparoscopic liver resection

Trials testing the same drug.

Other recruiting trials for Liver Tumor

Currently open trials in the same condition.

Other Medical University of Warsaw trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05516394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing